Search

Subject OSTEOPOROSIS -- ANABOLICS -- FRACTURE RISK ASSESSMENT

1. FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. (17th May 2018)

Authors:
Cosman, Felicia; Crittenden, Daria B; Ferrari, Serge; Khan, Aliya; Lane, Nancy E; Lippuner, Kurt; Matsumoto, Toshio; Milmont, Cassandra E; Libanati, Cesar; Grauer, Andreas
Journal:
Journal of bone and mineral research
Issue:
Volume 33:Number 7(2018)
Page Start:
1219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • OSTEOPOROSIS -- ANABOLICS -- FRACTURE RISK ASSESSMENT 1